Scientist Jarrett Bilton, PhD, recently travelled to the 25th North American ISSX conference in Boston. In collaboration with researchers at Genentech, RepliGut® Planar Jejunum was evaluated for gene expression patterns. The focus was on understanding how RepliGut Planar Jejunum responds to prototypical metabolic inducers Rifampin, CITCO, 3-MC, and Calcitriol. The poster shows the suitability of RepliGut® Planar Jejunum. It is used for studying the contribution of intestinal epithelial cells. These cells play a significant role in drug-drug interactions.